1. Home
  2. ERIC vs RMD Comparison

ERIC vs RMD Comparison

Compare ERIC & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ericsson

ERIC

Ericsson

N/A

Current Price

$11.40

Market Cap

37.8B

Sector

Technology

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

N/A

Current Price

$232.91

Market Cap

36.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERIC
RMD
Founded
1876
1989
Country
Sweden
United States
Employees
89898
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.8B
36.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ERIC
RMD
Price
$11.40
$232.91
Analyst Decision
Hold
Buy
Analyst Count
2
11
Target Price
$10.40
$293.70
AVG Volume (30 Days)
6.1M
880.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.70%
1.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.64
Revenue Next Year
$1.46
$7.38
P/E Ratio
$12.13
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$6.96
$199.92
52 Week High
$11.64
$293.81

Technical Indicators

Market Signals
Indicator
ERIC
RMD
Relative Strength Index (RSI) 55.91 30.76
Support Level $9.37 N/A
Resistance Level $11.64 $259.37
Average True Range (ATR) 0.26 5.62
MACD -0.04 -2.38
Stochastic Oscillator 69.54 5.87

Price Performance

Historical Comparison
ERIC
RMD

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: